Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Janice Drew"'
Autor:
Georgina L Hold, Susan Berry, Karin A Saunders, Janice Drew, Claus Mayer, Heather Brookes, Nick J Gay, Emad M El-Omar, Clare E Bryant
Publikováno v:
PLoS ONE, Vol 9, Iss 11, p e111460 (2014)
Dysregulated Toll-Like Receptor (TLR) signalling and genetic polymorphisms in these proteins are linked to many human diseases. We investigated TLR4 functional variants D299G and T399I to assess the impact on LPS-induced responsiveness in comparison
Externí odkaz:
https://doaj.org/article/00f6564b2db24b8cae4420cc91841f22
Publikováno v:
Clinical Pharmacokinetics
Background Glycopyrronium tosylate (GT; Qbrexza® [glycopyrronium] cloth, 2.4%) is a topical anticholinergic approved (USA) for primary axillary hyperhidrosis in patients aged ≥ 9 years. Objective The objective of this study was to compare the phar
Autor:
Janice Drew, Adelaide A. Hebert, Lawrence Green, Dee Anna Glaser, David M. Pariser, William Philip Werschler, Douglass W. Forsha, Ramanan Gopalan
Publikováno v:
Pediatric Dermatology
Objectives Hyperhidrosis in pediatric patients has been understudied. Post hoc analyses of two phase 3 randomized, vehicle‐controlled, 4‐week trials (ATMOS‐1 [NCT02530281] and ATMOS‐2 [NCT02530294]) were performed to assess efficacy and safet
Autor:
Adelaide A. Hebert, Ramanan Gopalan, David M. Pariser, Dee Anna Glaser, Janice Drew, John Quiring
Publikováno v:
American Journal of Clinical Dermatology
Background Glycopyrronium tosylate (GT) is a topical anticholinergic approved in the USA for primary axillary hyperhidrosis in patients aged ≥ 9 years. GT was evaluated for primary axillary hyperhidrosis in replicate, randomized, double-blind, vehi
Autor:
Ramanan Gopalan, Adelaide A. Hebert, Jennifer Clay Cather, Lawrence Green, David M. Pariser, Janice Drew, Cheryl Hull, Dee Anna Glaser
Publikováno v:
Pediatric Dermatology
Background/Objectives Glycopyrronium tosylate (GT) cloth, 2.4% is a topical anticholinergic approved in the United States for primary axillary hyperhidrosis in patients ≥9 years. This post hoc analysis evaluated long‐term response (efficacy and s
Autor:
Dee Anna Glaser, Janice Drew, Alexander Nast, Adelaide A. Hebert, John Quiring, William Philip Werschler, Richard Mamelok, Lawrence Green, David M. Pariser
Publikováno v:
American Journal of Clinical Dermatology
Background Glycopyrronium tosylate is a topical anticholinergic approved in the USA for primary axillary hyperhidrosis in patients aged ≥ 9 years (Qbrexza™ [glycopyrronium] cloth, 2.4%). Objective This 44-week open-label extension study assessed
Autor:
Janice Drew, Amy S. Paller, Eric L. Simpson, Lawrence F. Eichenfield, Emma Guttman-Yassky, Ramanan Gopalan, Andrew Blauvelt, April W. Armstrong
Publikováno v:
Journal of the American Academy of Dermatology. 83:AB63
Autor:
Amy S. Paller, Janice Drew, Emma Guttman-Yassky, Eric L. Simpson, R Gopalan, A Blauvelt, April W. Armstrong, Lawrence Eichenfield
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 4:s94
not available.
Autor:
April W. Armstrong, Amy S. Paller, Ramanan Gopalan, Emma Guttman-Yassky, M Janice Drew, Lawrence F. Eichenfield, Eric L. Simpson, Andrew Blauvelt
Publikováno v:
JAMA Dermatology. 156:411
IMPORTANCE: Interleukin 13 (IL-13) is a central pathogenic mediator driving multiple features of atopic dermatitis (AD) pathophysiology. OBJECTIVE: To evaluate the efficacy and safety of lebrikizumab, a novel, high-affinity, monoclonal antibody targe
Autor:
Emma Guttman-Yassky, Janice Drew, Eric L. Simpson, R Gopalan, Amy S. Paller, April W. Armstrong, Lawrence F. Eichenfield, A Blauvelt
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 3:S41
not available.